Clinical Trial Update: Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC [Phase 3]

View source ↗

Summary

A Phase 3 trial update comparing infusional FOLFOX plus Camrelizumab and Apatinib versus HAIC-FOLFOX plus Camrelizumab and Apatinib for advanced hepatocellular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• FOLFOX

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: BCLC Stage C Hepatocellular Carcinoma, Chemotherapy Effect | Phase 3 | Status: RECRUITING